Dr. Susie Cheng’s Article about Patent-Eligible Subject Matter Published in WIPO Magazine

Patent-eligible subject matter was at issue in the Supreme Court ruling in Mayo v. Prometheus and the Federal Circuit’s decision in AMP v. USPTO (“Myriad”).  Dr. Susie Cheng’s article, published in the December 2012 issue of WIPO Magazine, discusses the Courts’ approach as to which pharmaceutical and biotechnology inventions are considered as patent-eligible subject matter. 

Download PDF